According to the relevance of FAP as prognostic and predictive biomarker, FAP-targeted molecules such as small molecule inhibitors (FAPIs) are of interest as radioactive theranostic drugs used to diagnose and treat the primary and any metastatic tumors. This evidence concerns the gene FAP and metastatic neoplasm.